51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 523 / 薬物数 : 608 - (DrugBank : 156) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 215

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03558854 (ClinicalTrials.gov)	August 28, 2018	3/5/2018	Evaluation of Effectiveness of Acetylsalicylic Acidon Markers of Vascular Dysfunction in Scleroderma ...	Evaluation of Effectiveness of Acetylsalicylic Acidon Markers of Vascular Dysfunction in Patients Wi ...	Systemic Sclerosis	Drug: Acetylsalicylic acid;Drug: Placebo oral capsule	Federal University of São Paulo	NULL	Completed	18 Years	65 Years	All	70	Phase 4	Brazil
2	EUCTR2009-013468-37-GB (EUCTR)	29/09/2010	17/03/2010	A short-term open-label single site pilot study evaluating the use of asasantin retard therapy in th ...	A short-term open-label single site pilot study evaluating the use of asasantin retard therapy in th ...	Primary Raynaud's Phenomenon and Systemic Sclerosis MedDRA version: 12.1;Level: LLT;Classification c ...	Trade Name: Asasantin Retard ® Product Name: ASASANTIN Retard INN or Proposed INN: aspirin INN or Propos ...	Royal National Hospital for Rheumatic Disease	NULL	Not Recruiting			Female: yes Male: yes	70	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	United Kingdom

First Previous1Next Last